This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Götrick, B. Articles by Tobin, G. Search for Related Content PubMed PubMed Citation Articles by Götrick, B. Articles by Tobin, G. Social Bookmarking                         What's this?

Oral Pilocarpine for Treatment of Opioid-induced Oral Dryness in Healthy Adults

¹ Department of Hospital Dentistry and
⁴ Hospital Pharmacy, Malmö University Hospital, SE-205 02 Malmö, Sweden;
² Department of Oral Diagnostics and
³ Department of Cariology, Faculty of Odontology, Malmö University, SE-205 06 Malmö, Sweden; and
⁵ Department of Pharmacology, Göteborg University, Box 431, SE-405 30 Göteborg, Sweden;

View larger version (16K): [in this window] [in a new window]   Figure 1. Mean flow rates of unstimulated whole saliva in the pilocarpine group ( ; n = 17), placebo group (• ; n = 17), and control group ( ; n = 14) before (baseline, day 1), after the tramadol regime (50 mg x 5; dryness, day 3) and after pilocarpine/placebo treatment (5 mg x 1; treatment, day 3) or no further treatment (control). Tablet containing pilocarpine/placebo was administered on day 3 at –15 min (arrow). Values are mean ± SEM.

View larger version (12K): [in this window] [in a new window]   Figure 2. Changes in the flow of saliva (the mean flow rate over the periods; i.e., baseline, dryness, and active treatment periods) vs. the subjects’ own estimations of changes in the flow of saliva after (a) tramadol treatment (dryness level compared with baseline level) in 60 subjects (n = 48 in "Decrement group"; n = 12 in "No change group") and after (b) pilocarpine/placebo treatment (treatment level compared with dryness level) in 34 subjects (n = 5 in "Decrement group"; n = 13 in "No change group"; n = 16 in "Increment group"). Each symbol represents one individual.

Journal of Dental Research, Vol. 83, No. 5, 393-397 (2004)
DOI: 10.1177/154405910408300508


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?